RELIGN Corporation

RELIGN Corporation is a startup company based in Campbell, California. The company employs 8 people and generates $7.6 million in annual revenue. RELIGN specializes in developing innovative products for arthroscopy and resection, focusing on providing surgeons with advanced tools for enhanced efficiency and control. Their flagship product, the Tricera™ System, is a revolutionary platform that integrates ablation/coagulation, tissue resection, bone cutting, and fluid management capabilities into a single, streamlined system. The Tricera System's software allows surgeons to precisely manage these functions simultaneously, providing unparalleled control over the arthroscopic environment. RELIGN's commitment to innovation extends beyond the Tricera System, with a portfolio of versatile surgical devices featuring smaller reciprocating electrodes for aggressive tissue ablation and resection, as well as devices combining bone burring, resection, and ablation functionalities. These combination features enable exceptional device performance and control, allowing surgeons to switch modes seamlessly during procedures. RELIGN Corporation can be reached via their website at religncorp.com.